patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: EDIGOKIE..au'contrai... am positive, very much so!
This kind of tech does take "time". However, I'd like to know why they did the RS to get on the NASDAQ "when" they did it. This is what makes me leary. They could easily get delisted in a couple of months from the NAS if this stock keeps going in this direction. IMO - if their tech works, they should have waited to do the RS and stay on the OTC BB until they actually hit a major milestone or had some substantial news.
Share
New Message
Please login to post a reply